IRIS
FILICE, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.536
AS - Asia 4.315
EU - Europa 3.237
SA - Sud America 495
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 109
OC - Oceania 11
Totale 14.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.401
CN - Cina 2.272
SG - Singapore 903
IE - Irlanda 764
UA - Ucraina 466
HK - Hong Kong 386
DE - Germania 384
VN - Vietnam 359
RU - Federazione Russa 346
BR - Brasile 341
FI - Finlandia 299
FR - Francia 227
IT - Italia 209
SE - Svezia 199
GB - Regno Unito 166
IN - India 84
CA - Canada 71
BD - Bangladesh 59
AR - Argentina 48
ZA - Sudafrica 46
IQ - Iraq 39
PL - Polonia 36
CO - Colombia 33
MX - Messico 33
ES - Italia 32
JP - Giappone 31
EC - Ecuador 27
NL - Olanda 24
BE - Belgio 23
SA - Arabia Saudita 18
ID - Indonesia 16
TR - Turchia 16
VE - Venezuela 16
PH - Filippine 15
MA - Marocco 12
MY - Malesia 12
AT - Austria 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
LT - Lituania 9
CL - Cile 8
KR - Corea 8
NP - Nepal 8
PE - Perù 8
PK - Pakistan 8
PT - Portogallo 8
TN - Tunisia 8
AZ - Azerbaigian 7
ET - Etiopia 7
UZ - Uzbekistan 7
EG - Egitto 6
IL - Israele 6
IR - Iran 6
PY - Paraguay 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
HN - Honduras 5
JM - Giamaica 5
KZ - Kazakistan 5
AM - Armenia 4
EU - Europa 4
MD - Moldavia 4
TH - Thailandia 4
UY - Uruguay 4
CH - Svizzera 3
KE - Kenya 3
LB - Libano 3
MU - Mauritius 3
RO - Romania 3
SC - Seychelles 3
SN - Senegal 3
AG - Antigua e Barbuda 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
DM - Dominica 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
Totale 14.681
Salva come PNG Salva come JPEG
Città #
Dublin 762
San Jose 748
Chandler 740
Jacksonville 563
Ashburn 501
Nanjing 497
Singapore 449
Hong Kong 377
Beijing 369
Council Bluffs 327
Dallas 320
Boardman 238
Nanchang 215
Princeton 178
Houston 167
Lawrence 155
Changsha 151
Shenyang 145
Ho Chi Minh City 138
Lauterbourg 137
Hebei 134
Medford 133
Wilmington 127
Los Angeles 123
Jiaxing 106
New York 97
Tianjin 91
Ann Arbor 87
Hangzhou 77
Hanoi 74
Helsinki 72
Buffalo 62
Munich 61
Shanghai 60
Moscow 52
Redondo Beach 51
Santa Clara 51
Milan 48
Johannesburg 36
São Paulo 34
Brooklyn 31
Turku 30
Norwalk 29
Tokyo 29
Orem 28
Woodbridge 26
Falkenstein 25
Chicago 24
Frankfurt am Main 24
Chennai 23
Verona 23
Montreal 22
Phoenix 21
Warsaw 21
Brussels 20
Denver 20
San Francisco 20
Baghdad 19
Seattle 18
The Dalles 18
Des Moines 17
Fairfield 16
Zhengzhou 16
Haiphong 15
Pavia 15
London 14
Quito 14
Rome 14
Brasília 13
Da Nang 13
Toronto 13
Atlanta 12
Rio de Janeiro 12
Washington 12
Biên Hòa 11
Columbus 11
Guangzhou 11
Kunming 11
Mexico City 11
Ningbo 11
Amsterdam 10
Curitiba 10
Jinan 10
Nuremberg 10
Poplar 10
Amman 9
Boston 9
Dhaka 9
Jeddah 9
Manchester 9
Mumbai 9
Falls Church 8
Guayaquil 8
Orange 8
Porto Alegre 8
Pune 8
Buenos Aires 7
Kuala Lumpur 7
Medellín 7
Miami 7
Totale 9.658
Salva come PNG Salva come JPEG
Nome #
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1 184
Aggressive daily interferon therapy in HIV-HCV coinfected patients 157
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 156
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 153
Predictors of bacterial pneumonia in Evaluation of SUbcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). 148
Accuracy of ultrasound imaging technique for assessing lipoatrophy in HIV-infected subjects. 142
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. 140
The Pavia consensus statement 139
In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics 138
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1 136
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study 133
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 133
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 133
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure 132
Host factors affecting the outcome of treatment of hepatitis C 131
Mice and rabbits: Animal models for HIV-1 infection 131
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 127
[New trends in the therapy of cryptococcosis in AIDS patients] 127
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 126
IgM-IFA, IgM-ELISA, DS-IgM-ELISA, IgM-ISAGA, performed on whole serum and IgM fractions, for detection of IgM anti-toxoplasma antibodies during pregnancy 125
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 125
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 124
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera 124
Chemotherapy of toxoplasmic encephalitis in AIDS patients 124
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 122
A New complement fixation test for toxoplasmosis. Comparison with other serological methods 121
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 119
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor 115
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. 115
An improved method for increasing the sensitivity of direct agglutination test (D.A.T.) to the detection of IgM and IgG anti-toxoplasma antibodies 115
Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis 114
Prevalence of HIV-1 inetgrase mutations related to resistance to dolutegravir in raltegravir naive and pretrated patients. 114
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 114
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 113
A comparison of IHA and ELISA tests in the detection of antibodies to entamoeba histolytica 113
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. 113
Comparison between IgM-IFA and DS-IgM-ELISA performed on IgM fractions and whole sera in acute acquired toxoplasmosis 112
A novel methodology for large-scale phylogeny partition 111
Management of hepatitis C in human immunodeficiency virus-infected patients 110
Human immunodeficiency virus (HIV): an ultrastructural study 110
Transfusion-transmitted virus infection in HIV-1-seropositive patients 108
Point shear wave elastography method for assessing liver stiffness. 108
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 108
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 107
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 106
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 106
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers 106
General issues on microbial translocation in HIV-infected patients 106
[Protocols for the diagnostic verification of lymph node toxoplasmosis] 106
Hepatotoxicity and nelfinavir: a meta-analysis 105
Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. 105
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 105
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 103
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 102
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 102
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 102
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 102
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 102
Detection of IgM anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis 101
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 101
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 101
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers 101
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study 100
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 100
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 99
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 99
Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides 98
Minimal invasive Treatment for Hydatid Abdominal Cysts: PAIR (Puncture, Aspiration, Injection, Reaspiration)- State of the Art 97
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 97
Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies 97
Malattie Infettive 96
A comparative ultrastructural study of the low virulent strain PV-C1/81 and RH strain cultured in A9, Vero, SIRC cell lines 95
Rate of CD4+ cell count increase over periods of viral load suppressione: relationship with the number of previous virological failures. 94
Malattie Infettive 93
Fungaemia in hospitalized patients 93
Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. 92
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 92
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 92
Transverse myelitis associated with Mycoplasma pneumoniae pneumonitis: a report of two cases 92
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis 92
Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41). 92
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients 92
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 91
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 91
Entamoebiasi e parassitosi intestinali in un centro di ricovero psichiatrico.Valutazione di efficacia di protocolli di trattamento chemioprofilattico-chemioterapeutico 90
Behavioral correlates of adherence to antiretroviral therapy 90
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 89
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 89
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 88
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 88
Pathogenesis of liver damage in HCV-HIV patients 88
Manuale di Virologia Clinica 87
Natural history of chronic hepatitis B in co-infected patients. 87
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 87
Tuberculosis meningitis in adults: 5 cases 86
Evolution of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy from 2000 to 2010. 86
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients 86
Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection. 85
Prevalence of metabolic syndrome among HIV patients 85
Pathogenesis of liver damage in HCV-HIV patients. 84
Totale 10.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 0 0 0 3 12 10 17 42 31 5 112 404
2022/20232.120 244 152 16 173 220 217 0 116 893 9 44 36
2023/2024641 63 126 29 38 72 166 12 54 8 17 17 39
2024/20251.774 38 180 35 60 18 69 67 124 447 40 200 496
2025/20264.656 333 337 513 499 544 182 919 151 394 395 222 167
2026/20271.047 87 276 303 381 0 0 0 0 0 0 0 0
Totale 14.865